Literature DB >> 33845597

Cerebral venous sinus thrombosis due to external compression of internal jugular vein.

Jingwei Guan1,2,3, Siying Song1,2,3, Wei Wang1, Xunming Ji2,3,4, Ran Meng1,2,3.   

Abstract

Cerebral venous sinus thrombosis (CVST) is a special subtype of stroke that may be life-threatening in severe cases. CVST has distinct risk factors and is frequently overlooked because of its initially nonspecific clinical presentation. We herein describe a 72-year-old man who developed CVST in the right lateral sinus. Despite the absence of common risk factors in this patient, he developed external compression of the bilateral internal jugular veins by a lateral mass of the C1 vertebra and expansion of the carotid artery. Because of his elevated D-dimer and fibrinogen concentrations, which are associated with ongoing activation of the coagulation system, the patient underwent treatment with batroxobin combined with anticoagulation. Recanalization of the sinus was achieved, and his high intracranial pressure and papilledema remarkably decreased. We conclude that external compression of the internal jugular veins, which can be identified with three-dimensional computed tomography venography, may be an important risk factor for CVST.

Entities:  

Keywords:  Lateral sinus thrombosis; batroxobin; case report; computed tomography venography; internal jugular vein; risk factors; venous insufficiency

Year:  2021        PMID: 33845597     DOI: 10.1177/03000605211006609

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  2 in total

1.  Nonthrombotic internal jugular venous stenosis may facilitate cerebral venous thrombosis.

Authors:  Xiaoqin Wu; Jingyuan Ya; Da Zhou; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  CNS Neurosci Ther       Date:  2021-08-16       Impact factor: 5.243

Review 2.  Cerebral Complications of Snakebite Envenoming: Case Studies.

Authors:  Yu-Kai Huang; Yen-Chia Chen; Chia-Chun Liu; Hui-Chun Cheng; Anthony T Tu; Kun-Che Chang
Journal:  Toxins (Basel)       Date:  2022-06-27       Impact factor: 5.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.